Clinical Trials List
2018-06-15 - 2021-06-30
Phase III
Recruiting6
ICD-10C67
Malignant neoplasm of bladder
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Cheng-Kuang Yang Division of Urology
- 熊小澐 Division of Urology
- 裘坤元 Division of Urology
- Chia-Yen Lin Division of Urology
- Shian-Shiang Wang Division of Urology
- 王樹吉 Division of Urology
- Cheng-Che Chen Division of Urology
- Chuan-Shu Chen Division of Urology
- 洪晟鈞 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Sheng-Chen Wen Division of Urology
- 阮雍順 Division of Urology
- 黃俊農 Division of Urology
- Tsung-Yi Huang Division of Urology
- Yung-Chin Lee Division of Urology
- CHIA CHU LIU Division of Urology
- Hung-Lung Ke Division of Urology
- Ching-Chia Li Division of Urology
- Shu-Pin Huang Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Jiann-Hui Ou Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Yuh-Shyan Tsai Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- CHUNG-HSIN CHEN Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Hematology & Oncology
- YU-CHUAN LU Division of Hematology & Oncology
- 洪士鈞 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Taiwan National PI
Co-Principal Investigator
- Po-Jung Su Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- 張英勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
3 Recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
550 participants
